Salesforce Takes on Veeva in Pharmaceutical CRM Market - News and Statistics - IndexBox
Summary
Salesforce Inc. has announced a significant pivot in its strategy, targeting the pharmaceutical sector by taking several large customers from its former partner, Veeva Systems Inc. You can read the full story here. Veeva Systems, historically a dominant player with more than 80% market share in pharmaceutical-focused customer relationship management (CRM) software, generated an estimated $2.72 billion in annual revenue for the year ending in January. According to data from IndexBox, the CRM software market is seeing growth, driven by increased demand for specialized solutions in industries like pharmaceuticals. The company is reportedly staffing development teams at a rapid pace and is in discussions with major pharmaceutical firms for potential collaborations on its new product. Amidst Salesforces assertive entry, Veeva has reiterated its confidence in retaining a majority of its customer base, with commitments from significant players like GSK Plc and Novo Nordisk A/S.